The global glutamine market was valued at USD 135.13 million in 2024 and is projected to grow to USD 185.16 million by 2034. This represents a compound annual growth rate (CAGR) of 3.2% over the forecast period from 2024 to 2034.
Download statistics of this report @ https://www.towardshealthcare.com/download-statistics/5119
The glutamine market is on the rise, with L-glutamine leading the way, commanding 83% of the market share in 2023. The biggest demand is coming from muscle-building applications, which made up 36% of the market that year. North America holds the largest share, accounting for 40%, but other regions are quickly catching up as interest in fitness grows globally.
A standout product in the market is MuscleTech Platinum 100% Glutamine, a high-quality sports nutrition supplement made from pure L-glutamine powder. Studies show that it helps muscles recover faster and reduces soreness after exercise, making it a popular choice among athletes for its training benefits.
The glutamine market has seen substantial growth due to its wide range of uses and the increasing awareness of its health benefits. As an essential amino acid, glutamine plays a vital role in protein building, supports immune health by boosting the body’s defense against infections, and helps maintain digestive health, especially the integrity of the intestinal lining. With these benefits in mind, glutamine has become a widely used dietary supplement, recognized for its positive impact on overall well-being.
Several leading companies are driving the growth of the glutamine market:
Our Table of Content (TOC) covers key healthcare market segments, materials, technologies and trends—helping you navigate market shifts and make informed decisions: https://www.towardshealthcare.com/table-of-content/glutamine-market-sizing
Access exclusive insight now @ https://www.towardshealthcare.com/price/5119
We’ve prepared a service to support you. Please feel free to contact us at sales@towardshealthcare.com
Web: https://www.towardshealthcare.com
Visit Dental Specifics: https://www.towardsdental.com
Get the latest insights on industry segmentation with our Annual Membership: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare
The global continuous glucose monitoring devices market size is calculated at USD 4.97 in 2024. Living with diabetes in Canada… Read More
The surgical sutures market in the United States is showing steady and promising growth, and here’s why! 👇 👵👴 An… Read More
Azenta Life Sciences and Frenova, a division of Fresenius Medical Care and a leader in renal precision medicine, have announced… Read More
Zenara Pharma Private Limited, a leading Biophore company, has received final approval from the U.S. Food and Drug Administration (FDA)… Read More
Silexion Therapeutics Corp., a global clinical-stage biotech company specializing in RNA interference (RNAi) therapies, has announced outstanding new preclinical data… Read More
Canada and the UK have joined forces in a groundbreaking project aimed at developing next-generation immunotherapies for malignant melanoma, a… Read More